)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
The United Laboratories International
The United Laboratories International (3933) investor relations material
The United Laboratories International H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary31 Aug, 2026
Executive summary
Revenue for H1 2026 was RMB6,165.9 million, down 18.0% year-over-year, with gross profit decreasing 46.0% to RMB2,119.5 million and EBITDA falling 66.5% to RMB920.8 million.
Profit attributable to owners was RMB347.6 million, an 81.6% decline year-over-year; basic EPS was RMB17.62 cents, down from RMB104.26 cents.
All business segments faced challenging market conditions, with finished products revenue dropping 27.9% and intermediate products down 14.2%, while bulk medicine grew 5.0%.
R&D investment totaled RMB469.1 million, down 14.8% year-over-year, with 40 new drug products and 67 animal healthcare products under development.
No interim dividend was declared for H1 2026, compared to RMB16 cents per share in the prior year.
Financial highlights
Segmental revenue: intermediate products RMB1,976.5m (-14.2%), bulk medicine RMB3,148.4m (+5.0%), finished products RMB2,866.6m (-27.9%).
Segmental profit: intermediate products RMB191.4m (-69.8%), bulk medicine RMB79.7m (-68.2%), finished products RMB398.0m (-73.6%).
Finance costs rose 116.1% YoY to RMB44.9 million due to increased project financing.
Net bank balances and cash after deducting borrowings and supplier finance: RMB3,416.0 million.
Basic EPS: RMB17.62 cents (down 83.1% YoY).
Outlook and guidance
The Group will accelerate R&D and clinical development of innovative products, deepen vertical integration, and pursue international expansion.
Industry transformation and policy support for innovative drugs are expected to drive future growth.
Remaining proceeds from the 2025 share placing are expected to be fully utilised by 2028.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from The United Laboratories International
- Finished product and insulin sales soared despite revenue decline, with global expansion and innovation.3933
H2 2025 - Net profit rose 16.1% on higher revenue and strong segment performance, with robust R&D investment.3933H1 2024
- Stable revenue, higher R&D, and global expansion drive growth amid margin pressure.3933H2 2024
- Net profit rose 27% on strong finished products growth and major licensing deals.3933H1 2025
Next The United Laboratories International earnings date
H2 202623 Mar, 2027
The United Laboratories International
Next The United Laboratories International earnings date
H2 202623 Mar, 2027
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage